Precision Oncology Today
The discovery of these new Cas enzymes really catalyzed researchers to investigate how CRISPR technology could be used in diagnostics and over the last few years several biotech companies have been set up to explore this potential.
For anyone in the clinical trial field, no matter how peripherally, the onset of the COVID-19 pandemic was dramatic. Teams were mobilized for a full-throttle shift to decentralized clinical trials (DCTs).
Trending on Inside Precision Medicine
A new single cell map of human ovary and testis development brings new insights into how sex is determined in the womb.
A €2.5 million grant has been awarded toward development of a targeted ALS vaccine that aims to address the 5–10% of cases caused by the most common variant linked to the disease.
Researchers at the University of California at Santa Cruz have developed a new genome editing system, developed in Drosophila, that performs efficient somatic repair of both double strand breaks (DSBs) and single-strand breaks (SSBs) using intact sequences from the homologous chromosome.